1. Home
  2. IMTX vs FBYDP Comparison

IMTX vs FBYDP Comparison

Compare IMTX & FBYDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immatics N.V.

IMTX

Immatics N.V.

SELL

Current Price

$6.21

Market Cap

992.8M

Sector

Health Care

ML Signal

SELL

FBYDP

Falcon's Beyond Global Inc. 11% Series B Cumulative Convertible Preferred Stock

N/A

Current Price

$5.09

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
IMTX
FBYDP
Founded
N/A
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
992.8M
1.1B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
IMTX
FBYDP
Price
$6.21
$5.09
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $15.97
N/A
AVG Volume (30 Days)
★ 1.0M
2.2K
Earning Date
11-10-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $14,896,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.22
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 120.85
52 Week Low
$6.07
$4.60
52 Week High
$12.41
$9.71

Technical Indicators

Market Signals
Indicator
IMTX
FBYDP
Relative Strength Index (RSI) 33.37 39.62
Support Level N/A $4.60
Resistance Level $7.95 $7.95
Average True Range (ATR) 0.46 0.47
MACD -0.02 -0.23
Stochastic Oscillator 8.26 40.92

Price Performance

Historical Comparison
IMTX
FBYDP

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: